Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment - INTERACT

Description:

The goal of the INTERACT trial was to evaluate the safety and efficacy of unfractionated heparin (UFH) versus the low molecular weight heparin (LMWH) enoxaparin in combination with eptifibatide in treating patients with high-risk non-ST-segment elevation acute coronary syndrome (ACS).